An explainable machine learning model for predicting bladder tumor aecurrence risk.
Source check: Source checked. Not independent scientific confirmation.
Finding / tested result: Original Frontiers Methods/Results: retrospective cohort of 504 histologically confirmed NMIBC cases, with recurrence established by cystoscopy/histopathology; LASSO plus comparison of 11 ML algorithms selected seven-feature XGBoost, independent testing AUC .994. Single-center retrospective evaluation; external validation absent.
Technology: the ML/deep-learning operation used for the specific result.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- the ML/deep-learning operation used for the specific result.
- Limitation / still unknown
- Results are limited to the reported models, cohorts, datasets or experiments; broader generalization and clinical or operational benefit were not established.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2026.1728056/full
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.